Celiac Disease Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: C842610B8DBBEN
Market Monitor Global

Abstracts

Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.

This report contains market size and forecasts of Celiac Disease Drugs in Global, including the following market information:

Global Celiac Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Celiac Disease Drugs market was valued at 614.6 million in 2021 and is projected to reach US$ 1560.7 million by 2028, at a CAGR of 14.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

First Line of Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Celiac Disease Drugs include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Celiac Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Celiac Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Celiac Disease Drugs Market Segment Percentages, by Type, 2021 (%)

• First Line of Treatment
• Second Line of Treatment

Global Celiac Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Celiac Disease Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Celiac Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Celiac Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Celiac Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Celiac Disease Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Merck
• Johnson & Johnson
• BiolineRx
• Pfizer
• Innovate Biopharmaceuticals
• ImmusanT
• Novartis
• Bristol-Myers Squibb
• Immunomedics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Celiac Disease Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Celiac Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELIAC DISEASE DRUGS OVERALL MARKET SIZE

2.1 Global Celiac Disease Drugs Market Size: 2021 VS 2028
2.2 Global Celiac Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Celiac Disease Drugs Players in Global Market
3.2 Top Global Celiac Disease Drugs Companies Ranked by Revenue
3.3 Global Celiac Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Celiac Disease Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Celiac Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Celiac Disease Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Celiac Disease Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Celiac Disease Drugs Market Size Markets, 2021 & 2028
  4.1.2 First Line of Treatment
  4.1.3 Second Line of Treatment
4.2 By Type - Global Celiac Disease Drugs Revenue & Forecasts
  4.2.1 By Type - Global Celiac Disease Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Celiac Disease Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Celiac Disease Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Celiac Disease Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
  5.1.5 Others
5.2 By Application - Global Celiac Disease Drugs Revenue & Forecasts
  5.2.1 By Application - Global Celiac Disease Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Celiac Disease Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Celiac Disease Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Celiac Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Celiac Disease Drugs Revenue & Forecasts
  6.2.1 By Region - Global Celiac Disease Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Celiac Disease Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Celiac Disease Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Celiac Disease Drugs Revenue, 2017-2028
  6.3.2 US Celiac Disease Drugs Market Size, 2017-2028
  6.3.3 Canada Celiac Disease Drugs Market Size, 2017-2028
  6.3.4 Mexico Celiac Disease Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Celiac Disease Drugs Revenue, 2017-2028
  6.4.2 Germany Celiac Disease Drugs Market Size, 2017-2028
  6.4.3 France Celiac Disease Drugs Market Size, 2017-2028
  6.4.4 U.K. Celiac Disease Drugs Market Size, 2017-2028
  6.4.5 Italy Celiac Disease Drugs Market Size, 2017-2028
  6.4.6 Russia Celiac Disease Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Celiac Disease Drugs Market Size, 2017-2028
  6.4.8 Benelux Celiac Disease Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Celiac Disease Drugs Revenue, 2017-2028
  6.5.2 China Celiac Disease Drugs Market Size, 2017-2028
  6.5.3 Japan Celiac Disease Drugs Market Size, 2017-2028
  6.5.4 South Korea Celiac Disease Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Celiac Disease Drugs Market Size, 2017-2028
  6.5.6 India Celiac Disease Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Celiac Disease Drugs Revenue, 2017-2028
  6.6.2 Brazil Celiac Disease Drugs Market Size, 2017-2028
  6.6.3 Argentina Celiac Disease Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Celiac Disease Drugs Revenue, 2017-2028
  6.7.2 Turkey Celiac Disease Drugs Market Size, 2017-2028
  6.7.3 Israel Celiac Disease Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Celiac Disease Drugs Market Size, 2017-2028
  6.7.5 UAE Celiac Disease Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Celiac Disease Drugs Major Product Offerings
  7.1.4 Roche Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Celiac Disease Drugs Major Product Offerings
  7.2.4 Merck Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Celiac Disease Drugs Major Product Offerings
  7.3.4 Johnson & Johnson Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 BiolineRx
  7.4.1 BiolineRx Corporate Summary
  7.4.2 BiolineRx Business Overview
  7.4.3 BiolineRx Celiac Disease Drugs Major Product Offerings
  7.4.4 BiolineRx Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.4.5 BiolineRx Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Celiac Disease Drugs Major Product Offerings
  7.5.4 Pfizer Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Innovate Biopharmaceuticals
  7.6.1 Innovate Biopharmaceuticals Corporate Summary
  7.6.2 Innovate Biopharmaceuticals Business Overview
  7.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Major Product Offerings
  7.6.4 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.6.5 Innovate Biopharmaceuticals Key News
7.7 ImmusanT
  7.7.1 ImmusanT Corporate Summary
  7.7.2 ImmusanT Business Overview
  7.7.3 ImmusanT Celiac Disease Drugs Major Product Offerings
  7.7.4 ImmusanT Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.7.5 ImmusanT Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Celiac Disease Drugs Major Product Offerings
  7.8.4 Novartis Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Celiac Disease Drugs Major Product Offerings
  7.9.4 Bristol-Myers Squibb Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 Immunomedics
  7.10.1 Immunomedics Corporate Summary
  7.10.2 Immunomedics Business Overview
  7.10.3 Immunomedics Celiac Disease Drugs Major Product Offerings
  7.10.4 Immunomedics Celiac Disease Drugs Revenue in Global Market (2017-2022)
  7.10.5 Immunomedics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Celiac Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Celiac Disease Drugs Market Drivers in Global Market
Table 3. Celiac Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Celiac Disease Drugs in Global Market
Table 5. Top Celiac Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Celiac Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Celiac Disease Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Celiac Disease Drugs Product Type
Table 9. List of Global Tier 1 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celiac Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Celiac Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Celiac Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Celiac Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Celiac Disease Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Celiac Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Celiac Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Celiac Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Celiac Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Celiac Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Celiac Disease Drugs Product Offerings
Table 32. Roche Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Celiac Disease Drugs Product Offerings
Table 35. Merck Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Celiac Disease Drugs Product Offerings
Table 38. Johnson & Johnson Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 39. BiolineRx Corporate Summary
Table 40. BiolineRx Celiac Disease Drugs Product Offerings
Table 41. BiolineRx Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Celiac Disease Drugs Product Offerings
Table 44. Pfizer Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Innovate Biopharmaceuticals Corporate Summary
Table 46. Innovate Biopharmaceuticals Celiac Disease Drugs Product Offerings
Table 47. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 48. ImmusanT Corporate Summary
Table 49. ImmusanT Celiac Disease Drugs Product Offerings
Table 50. ImmusanT Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Celiac Disease Drugs Product Offerings
Table 53. Novartis Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Celiac Disease Drugs Product Offerings
Table 56. Bristol-Myers Squibb Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Immunomedics Corporate Summary
Table 58. Immunomedics Celiac Disease Drugs Product Offerings
Table 59. Immunomedics Celiac Disease Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Celiac Disease Drugs Segment by Type in 2021
Figure 2. Celiac Disease Drugs Segment by Application in 2021
Figure 3. Global Celiac Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Celiac Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Celiac Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2021
Figure 8. By Type - Global Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 12. US Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 24. China Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Celiac Disease Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Celiac Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BiolineRx Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Innovate Biopharmaceuticals Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ImmusanT Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Immunomedics Celiac Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)